Hervé Bastian

Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis

A. Foussat, H. Asnagli, C. Jorgensen, 2014, Arthritis Research & Therapy.

Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation

M. Levings, E. Proics, M. Speck, 2022, Gene Therapy.

Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood.

A. Foussat, Y. Pers, C. Jorgensen, 2011, International immunopharmacology.

Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases.

A. Foussat, V. Brun, Hervé Bastian, 2009, International immunopharmacology.

Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.

A. Foussat, M. Ticchioni, P. Desreumaux, 2012, Gastroenterology.

Feasibility of manufacture of chimeric antigen receptor-regulatory T cells from patients with end-stage renal disease

D. Cantarovich, K. Schreeb, E. Culme-Seymour, 2023, Translational Medicine Communications.

Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.

A. Foussat, M. Ticchioni, P. Desreumaux, 2012, Gastroenterology.